摘要
目的:探讨生脉注射液联合注射用血塞通治疗冠心病的临床效果。方法:选择80例冠心病患者,随机分为观察组和对照组,对照组给予常规药物,观察组同时给予生脉注射液联合注射用血塞通。检测两组血液流变学指标,评定临床效果。结果:观察组治疗后血浆黏度、高切黏度、低切黏度低于对照组治疗后,差异有统计学意义(P<0.05)。观察组总有效率高于对照组,差异有统计学意义(P<0.05)。结论:生脉注射液联合注射用血塞通治疗冠心病疗效显著,能够显著改善患者血液黏滞度,值得借鉴。
Objective To investigate the clinical effect of Shengmai injection combined with Xuesaitong Injection in the treatment of coronary heart disease. Method 80 patients with coronary heart disease were randomly divided into the observation group and the control group. The control group was given conventional drugs,and the observation group was given Shengmai injection combined with Xuesaitong injection on the base of conventional drugs. Blood rheology indexes of two groups were detected and clinical effect was evaluated. Results In the observation group after treatment,plasma viscosity,high shear viscosity,low shear viscosity was lower than the control group after treatment,the difference was statistically significant（ P〈0. 05）. The total effective rate of the observation group was higher than that of the control group,the difference was statistically significant（ P〈0. 05）.Conclusion Shengmai injection combined with Xuesaitong injection is effective in the treatment of coronary heart disease,and which can significantly improve the blood viscosity of patients,so it is worth learning.
出处
《吉林医学》
CAS
2017年第11期2036-2037,共2页
Jilin Medical Journal
关键词
冠心病
生脉注射液
注射用血塞通
血液黏滞度
Coronary heart disease
Shengmai injection
Injection Xuesaitong
Blood viscosity
